Loading…

Fungal infections in immunocompromised critically ill patients

Diverse pathogenic fungi can produce severe infections in immunocompromised patients, thereby justifying intensive care unit (ICU) admissions. In some cases, the infections can develop in immunocompromised patients who were previously admitted to the ICU. Aspergillus spp., Pneumocystis jirovecii, Ca...

Full description

Saved in:
Bibliographic Details
Published in:Journal of intensive medicine 2024-07, Vol.4 (3), p.299-306
Main Authors: Garnacho-Montero, José, Barrero-García, Irene, León-Moya, Cristina
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c423t-41cc3ba1c31d439b6304b7ad6c53eb38f65c9bb50cd1530b813ea55ab2733743
container_end_page 306
container_issue 3
container_start_page 299
container_title Journal of intensive medicine
container_volume 4
creator Garnacho-Montero, José
Barrero-García, Irene
León-Moya, Cristina
description Diverse pathogenic fungi can produce severe infections in immunocompromised patients, thereby justifying intensive care unit (ICU) admissions. In some cases, the infections can develop in immunocompromised patients who were previously admitted to the ICU. Aspergillus spp., Pneumocystis jirovecii, Candida spp., and Mucorales are the fungi that are most frequently involved in these infections. Diagnosis continues to be challenging because symptoms and signs are unspecific. Herein, we provide an in-depth review about the diagnosis, with emphasis on recent advances, and treatment of these invasive fungal infections in the ICU setting.
doi_str_mv 10.1016/j.jointm.2024.01.005
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_53cf06ab63a7492aa26c304e06247c86</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2667100X2400015X</els_id><doaj_id>oai_doaj_org_article_53cf06ab63a7492aa26c304e06247c86</doaj_id><sourcerecordid>3083216754</sourcerecordid><originalsourceid>FETCH-LOGICAL-c423t-41cc3ba1c31d439b6304b7ad6c53eb38f65c9bb50cd1530b813ea55ab2733743</originalsourceid><addsrcrecordid>eNp9UU1P3TAQtCpQQcA_qKoce3lh_ZnkglQhoEhIXDhws-yNgxw58audVOLf149Q1BMnr63ZGc8MId8o1BSouhzrMfp5mWoGTNRAawD5hZwypZodBXg--m8-IRc5jwDA2nKV3VdywjvgUlF2Sq5u1_nFhMrPg8PFxzmXsfLTtM4R47RPcfLZ9RUmv3g0IbxWPoRqbxbv5iWfk-PBhOwu3s8z8nR783T9a_fweHd__fNhh4LxZScoIreGIqe94J1VHIRtTK9Qcmd5OyiJnbUSsKeSg20pd0ZKY1nDeSP4GbnfaPtoRr1PfjLpVUfj9dtDTC_apPK_4LTkOIAyRcI0omPGMIVFzYFiosFWFa4fG1fx9nt1edHFIboQzOzimjWHljOqGnmQFRsUU8w5ueFDmoI-9KBHvfWgDz1ooLoEXNa-vyusdnL9x9K_1AvgagO4Etkf75LOWOJE1_tUWiim_OcKfwEcGZpE</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3083216754</pqid></control><display><type>article</type><title>Fungal infections in immunocompromised critically ill patients</title><source>ScienceDirect Journals</source><source>PubMed Central</source><creator>Garnacho-Montero, José ; Barrero-García, Irene ; León-Moya, Cristina</creator><creatorcontrib>Garnacho-Montero, José ; Barrero-García, Irene ; León-Moya, Cristina</creatorcontrib><description>Diverse pathogenic fungi can produce severe infections in immunocompromised patients, thereby justifying intensive care unit (ICU) admissions. In some cases, the infections can develop in immunocompromised patients who were previously admitted to the ICU. Aspergillus spp., Pneumocystis jirovecii, Candida spp., and Mucorales are the fungi that are most frequently involved in these infections. Diagnosis continues to be challenging because symptoms and signs are unspecific. Herein, we provide an in-depth review about the diagnosis, with emphasis on recent advances, and treatment of these invasive fungal infections in the ICU setting.</description><identifier>ISSN: 2667-100X</identifier><identifier>EISSN: 2667-100X</identifier><identifier>DOI: 10.1016/j.jointm.2024.01.005</identifier><identifier>PMID: 39035612</identifier><language>eng</language><publisher>China: Elsevier B.V</publisher><subject>Antifungal ; Critically ill patient ; Immunocompromised patient ; Invasive aspergillosis ; Invasive candidiasis ; Pneumocystis jirovecii</subject><ispartof>Journal of intensive medicine, 2024-07, Vol.4 (3), p.299-306</ispartof><rights>2024</rights><rights>2024 The Authors. Published by Elsevier B.V. on behalf of Chinese Medical Association.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c423t-41cc3ba1c31d439b6304b7ad6c53eb38f65c9bb50cd1530b813ea55ab2733743</cites><orcidid>0000-0003-2542-7601</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S2667100X2400015X$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,777,781,3536,27905,27906,45761</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39035612$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Garnacho-Montero, José</creatorcontrib><creatorcontrib>Barrero-García, Irene</creatorcontrib><creatorcontrib>León-Moya, Cristina</creatorcontrib><title>Fungal infections in immunocompromised critically ill patients</title><title>Journal of intensive medicine</title><addtitle>J Intensive Med</addtitle><description>Diverse pathogenic fungi can produce severe infections in immunocompromised patients, thereby justifying intensive care unit (ICU) admissions. In some cases, the infections can develop in immunocompromised patients who were previously admitted to the ICU. Aspergillus spp., Pneumocystis jirovecii, Candida spp., and Mucorales are the fungi that are most frequently involved in these infections. Diagnosis continues to be challenging because symptoms and signs are unspecific. Herein, we provide an in-depth review about the diagnosis, with emphasis on recent advances, and treatment of these invasive fungal infections in the ICU setting.</description><subject>Antifungal</subject><subject>Critically ill patient</subject><subject>Immunocompromised patient</subject><subject>Invasive aspergillosis</subject><subject>Invasive candidiasis</subject><subject>Pneumocystis jirovecii</subject><issn>2667-100X</issn><issn>2667-100X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNp9UU1P3TAQtCpQQcA_qKoce3lh_ZnkglQhoEhIXDhws-yNgxw58audVOLf149Q1BMnr63ZGc8MId8o1BSouhzrMfp5mWoGTNRAawD5hZwypZodBXg--m8-IRc5jwDA2nKV3VdywjvgUlF2Sq5u1_nFhMrPg8PFxzmXsfLTtM4R47RPcfLZ9RUmv3g0IbxWPoRqbxbv5iWfk-PBhOwu3s8z8nR783T9a_fweHd__fNhh4LxZScoIreGIqe94J1VHIRtTK9Qcmd5OyiJnbUSsKeSg20pd0ZKY1nDeSP4GbnfaPtoRr1PfjLpVUfj9dtDTC_apPK_4LTkOIAyRcI0omPGMIVFzYFiosFWFa4fG1fx9nt1edHFIboQzOzimjWHljOqGnmQFRsUU8w5ueFDmoI-9KBHvfWgDz1ooLoEXNa-vyusdnL9x9K_1AvgagO4Etkf75LOWOJE1_tUWiim_OcKfwEcGZpE</recordid><startdate>20240701</startdate><enddate>20240701</enddate><creator>Garnacho-Montero, José</creator><creator>Barrero-García, Irene</creator><creator>León-Moya, Cristina</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-2542-7601</orcidid></search><sort><creationdate>20240701</creationdate><title>Fungal infections in immunocompromised critically ill patients</title><author>Garnacho-Montero, José ; Barrero-García, Irene ; León-Moya, Cristina</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c423t-41cc3ba1c31d439b6304b7ad6c53eb38f65c9bb50cd1530b813ea55ab2733743</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Antifungal</topic><topic>Critically ill patient</topic><topic>Immunocompromised patient</topic><topic>Invasive aspergillosis</topic><topic>Invasive candidiasis</topic><topic>Pneumocystis jirovecii</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Garnacho-Montero, José</creatorcontrib><creatorcontrib>Barrero-García, Irene</creatorcontrib><creatorcontrib>León-Moya, Cristina</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Journal of intensive medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Garnacho-Montero, José</au><au>Barrero-García, Irene</au><au>León-Moya, Cristina</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fungal infections in immunocompromised critically ill patients</atitle><jtitle>Journal of intensive medicine</jtitle><addtitle>J Intensive Med</addtitle><date>2024-07-01</date><risdate>2024</risdate><volume>4</volume><issue>3</issue><spage>299</spage><epage>306</epage><pages>299-306</pages><issn>2667-100X</issn><eissn>2667-100X</eissn><abstract>Diverse pathogenic fungi can produce severe infections in immunocompromised patients, thereby justifying intensive care unit (ICU) admissions. In some cases, the infections can develop in immunocompromised patients who were previously admitted to the ICU. Aspergillus spp., Pneumocystis jirovecii, Candida spp., and Mucorales are the fungi that are most frequently involved in these infections. Diagnosis continues to be challenging because symptoms and signs are unspecific. Herein, we provide an in-depth review about the diagnosis, with emphasis on recent advances, and treatment of these invasive fungal infections in the ICU setting.</abstract><cop>China</cop><pub>Elsevier B.V</pub><pmid>39035612</pmid><doi>10.1016/j.jointm.2024.01.005</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-2542-7601</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2667-100X
ispartof Journal of intensive medicine, 2024-07, Vol.4 (3), p.299-306
issn 2667-100X
2667-100X
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_53cf06ab63a7492aa26c304e06247c86
source ScienceDirect Journals; PubMed Central
subjects Antifungal
Critically ill patient
Immunocompromised patient
Invasive aspergillosis
Invasive candidiasis
Pneumocystis jirovecii
title Fungal infections in immunocompromised critically ill patients
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T17%3A50%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fungal%20infections%20in%20immunocompromised%20critically%20ill%20patients&rft.jtitle=Journal%20of%20intensive%20medicine&rft.au=Garnacho-Montero,%20Jos%C3%A9&rft.date=2024-07-01&rft.volume=4&rft.issue=3&rft.spage=299&rft.epage=306&rft.pages=299-306&rft.issn=2667-100X&rft.eissn=2667-100X&rft_id=info:doi/10.1016/j.jointm.2024.01.005&rft_dat=%3Cproquest_doaj_%3E3083216754%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c423t-41cc3ba1c31d439b6304b7ad6c53eb38f65c9bb50cd1530b813ea55ab2733743%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3083216754&rft_id=info:pmid/39035612&rfr_iscdi=true